3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
blinatumomab
2
Vincristine
2
Rituximab
2
Methotrexate
2
Cytarabine
2
Cyclophosphamide
2
prednylidene
1
pegaspargase
1
merphos
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
azathiopurine
1
auricularum
1
X-Rays
1
Stem Cell Transplantation
1
Spinal Puncture
1
Specimen Handling
1
Prednisone
1
Phantoms, Imaging
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Mercaptopurine
1
Leucovorin
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Daunorubicin
1
Calcium Dobesilate
1
CT-P10
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Burkitt Lymphoma
×
relatlimab
×
Clear all
No trials found.